Published in Thorax on October 01, 1993
Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin Microbiol Rev (2011) 2.23
Direct detection and identification of Pseudomonas aeruginosa in clinical samples such as skin biopsy specimens and expectorations by multiplex PCR based on two outer membrane lipoprotein genes, oprI and oprL. J Clin Microbiol (1997) 2.04
Auxotrophic variants of Pseudomonas aeruginosa are selected from prototrophic wild-type strains in respiratory infections in patients with cystic fibrosis. J Clin Microbiol (1995) 1.87
Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease. Thorax (2000) 1.37
Auxotrophy of Burkholderia (Pseudomonas) cepacia from cystic fibrosis patients. J Clin Microbiol (1995) 1.14
Comparison of the sensitivity of culture, PCR and quantitative real-time PCR for the detection of Pseudomonas aeruginosa in sputum of cystic fibrosis patients. BMC Microbiol (2009) 1.05
Genome macrorestriction analysis of sequential Pseudomonas aeruginosa isolates from bronchiectasis patients without cystic fibrosis. J Clin Microbiol (1996) 1.02
Characterization of Pseudomonas aeruginosa isolated from chronically infected children with cystic fibrosis in India. BMC Microbiol (2005) 0.96
Comparison of culture and qPCR for the detection of Pseudomonas aeruginosa in not chronically infected cystic fibrosis patients. BMC Microbiol (2010) 0.87
Pseudomonas aeruginosa syntrophy in chronically colonized airways of cystic fibrosis patients. Antimicrob Agents Chemother (2012) 0.84
Clinical application of a rapid microbiological test based on capillary zone electrophoresis to assess local skin infection. BMC Res Notes (2011) 0.75
Two simple media for the demonstration of pyocyanin and fluorescin. J Lab Clin Med (1954) 63.14
Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration. Am Rev Respir Dis (1989) 2.77
STUDIES ON PULMONARY SECRETIONS. I. THE OVER-ALL CHEMICAL COMPOSITION OF PULMONARY SECRETIONS FROM PATIENTS WITH CYSTIC FIBROSIS, BRONCHIECTASIS, AND LARYNGECTOMY. Am Rev Respir Dis (1963) 1.81
Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis. J Clin Microbiol (1987) 1.80
Conversion of Pseudomonas aeruginosa to the phenotype characteristic of strains from patients with cystic fibrosis. J Clin Microbiol (1990) 1.60
The identification of pseudomonads and related bacteria in a clinical laboratory. J Med Microbiol (1978) 1.37
Cystic fibrosis. 2. Lung injury in cystic fibrosis. Thorax (1990) 1.37
Auxotrophy of Pseudomonas aeruginosa in cystic fibrosis. FEMS Microbiol Lett (1992) 1.21
Biology of Pseudomonas aeruginosa in relation to pulmonary infection in cystic fibrosis. J R Soc Med (1986) 1.12
Strategies and perspectives in treatment of respiratory infections. Acta Paediatr Scand Suppl (1989) 0.92
Synergistic activity of 5-trifluoromethylthioribose and inhibitors of methionine synthesis against Klebsiella pneumoniae. Antimicrob Agents Chemother (1991) 0.90
Macromolecular and lipid constituents of bronchial epithelial mucus. Symp Soc Exp Biol (1989) 0.87
Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat Med (1995) 3.61
Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods. J Clin Microbiol (1996) 3.52
Imported melioidosis in England and Wales. Lancet (1999) 3.42
Identification of the cystic fibrosis gene. BMJ (1990) 3.28
Independent genetic determinants of pancreatic and pulmonary status in cystic fibrosis. Lancet (1990) 3.27
Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J (2000) 3.14
Q fever endocarditis treated with trimethoprim and sulphamethoxazole. Br Med J (1972) 3.06
Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii. Clin Microbiol Infect (2007) 3.00
Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease. J Clin Microbiol (2005) 2.95
Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis. Lancet (1981) 2.87
Liver disease and bile duct abnormalities in adults with cystic fibrosis. Lancet (1989) 2.76
The relationship of phenotype changes in Pseudomonas aeruginosa to the clinical condition of patients with cystic fibrosis. Am Rev Respir Dis (1983) 2.68
The relationship between the O-antigenic lipopolysaccharides and serological specificity in strains of Pseudomonas aeruginosa of different O-serotypes. J Gen Microbiol (1973) 2.61
High-dose beclomethasone inhaler in the treatment of asthma. Lancet (1983) 2.58
Epidemiological typing of klebsiellae with extended-spectrum beta-lactamases from European intensive care units. J Antimicrob Chemother (1998) 2.51
Wasting as an independent predictor of mortality in patients with cystic fibrosis. Thorax (2001) 2.50
Cystic fibrosis in adolescents and adults. Thorax (1987) 2.47
Discriminatory power of three DNA-based typing techniques for Pseudomonas aeruginosa. J Clin Microbiol (1995) 2.43
Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa. Infect Immun (1984) 2.39
Correlation of typing methods for Acinetobacter isolates from hospital outbreaks. J Clin Microbiol (1993) 2.38
Effects of long term inhaled high dose beclomethasone dipropionate on adrenal function. Thorax (1983) 2.35
Pilus-dependence of four Pseudomonas aeruginosa bacteriophages with non-contractile tails. J Gen Virol (1974) 2.23
Evaluation of the forced expiration technique as an adjunct to postural drainage in treatment of cystic fibrosis. Br Med J (1979) 2.15
Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission. J Clin Microbiol (1993) 2.12
Biochemical characteristics of clinical and environmental isolates of Burkholderia pseudomallei. J Med Microbiol (1996) 2.11
A prognostic model for the prediction of survival in cystic fibrosis. Thorax (1997) 2.10
Comparison of ribotyping with conventional methods for the type identification of Enterobacter cloacae. J Clin Microbiol (1991) 2.06
Meconium ileus equivalent in adults with cystic fibrosis of pancreas: a report of six cases. Br Med J (1976) 2.02
Management of pneumothorax in adults with cystic fibrosis. Thorax (1982) 1.99
Auxotrophic variants of Pseudomonas aeruginosa are selected from prototrophic wild-type strains in respiratory infections in patients with cystic fibrosis. J Clin Microbiol (1995) 1.87
Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis. QJM (1996) 1.78
Malignant mesothelioma of the pleura: relation between histological type and clinical behaviour. Thorax (1982) 1.76
Long term venous access using a totally implantable drug delivery system in patients with cystic fibrosis and bronchiectasis. Respir Med (1989) 1.75
A prevalent, multiresistant clone of Acinetobacter baumannii in Southeast England. J Hosp Infect (2004) 1.74
Improved survival at low lung function in cystic fibrosis: cohort study from 1990 to 2007. BMJ (2011) 1.74
Medium term treatment of stable stage cystic fibrosis with recombinant human DNase I. Thorax (1995) 1.72
2-Heptyl-4-hydroxyquinoline N-oxide, an antistaphylococcal agent produced by Pseudomonas aeruginosa. J Antimicrob Chemother (1992) 1.71
Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet (1999) 1.69
Latex agglutination test for identification of Pseudomonas pseudomallei. J Clin Pathol (1993) 1.67
Oral ciprofloxacin compared with conventional intravenous treatment for Pseudomonas aeruginosa infection in adults with cystic fibrosis. Lancet (1987) 1.66
Demographic and social characteristics of adults with cystic fibrosis in the United Kingdom. BMJ (1993) 1.65
Quality of life in adults with cystic fibrosis. Thorax (1996) 1.64
Mycobacterial isolations in young adults with cystic fibrosis. Thorax (1984) 1.60
Methicillin-resistant Staphylococcus aureus: impact at a national cystic fibrosis centre. J Hosp Infect (1998) 1.55
Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis. Eur Respir J (2000) 1.54
The high amino-acid content of sputum from cystic fibrosis patients promotes growth of auxotrophic Pseudomonas aeruginosa. J Med Microbiol (1996) 1.52
Hospital care for adults with cystic fibrosis: an overview and comparison between special cystic fibrosis clinics and general clinics using a patient questionnaire. Thorax (1994) 1.52
Interaction of corticosteroids and catecholamines in the treatment of asthma. Thorax (1975) 1.52
Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol (2001) 1.49
Characterisation of the normal right ventricular pressure-volume relation by biplane angiography and simultaneous micromanometer pressure measurements. Br Heart J (1988) 1.48
Burkholderia pseudomallei and Indian plague-like illness. Lancet (1995) 1.44
Circulating immune complexes in patients with cryptogenic fibrosing alveolitis. Clin Exp Immunol (1979) 1.44
Sweat tests to diagnose cystic fibrosis in adults. Br Med J (Clin Res Ed) (1983) 1.41
Twice vs three-times daily antibiotics in the treatment of pulmonary exacerbations of cystic fibrosis. J Cyst Fibros (2011) 1.40
Intermediate-term results of heart-lung transplantation for cystic fibrosis. Lancet (1992) 1.40
Inhalation of antibiotics in cystic fibrosis. Eur Respir J (1995) 1.39
Ribotype differences between clinical and environmental isolates of Burkholderia pseudomallei. J Med Microbiol (1997) 1.38
Relationships among Pseudomonas pseudomallei isolates from patients with recurrent melioidosis. J Clin Microbiol (1993) 1.37
Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease. Thorax (2000) 1.37
Importance of viruses and Legionella pneumophila in respiratory exacerbations of young adults with cystic fibrosis. Thorax (1984) 1.36
Linked marker haplotypes and the delta F508 mutation in adults with mild pulmonary disease and cystic fibrosis. Lancet (1990) 1.35
A comparison of flagellar typing and phage typing as means of subdividing the O groups of Pseudomonas aeruginosa. J Med Microbiol (1981) 1.34
Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis. J Pathol (1998) 1.34
Radiology of uncomplicated asthma. Thorax (1974) 1.33
Cystic fibrosis. Postgrad Med J (1984) 1.32
Nasal potential difference: a clinical diagnostic test for cystic fibrosis. Eur Respir J (1990) 1.32
Klebsiella pneumoniae infections in Greek hospitals. Dissemination of plasmids encoding an SHV-5 type beta-lactamase. J Hosp Infect (1995) 1.31
A cohort study of cystic fibrosis and malignancy. Br J Cancer (1993) 1.31
The specificity of agglutination reactions of Pseudomonas aeruginosa with O antisera. J Med Microbiol (1978) 1.29
Vertebral deformities and low bone mineral density in adults with cystic fibrosis: a cross-sectional study. Osteoporos Int (2001) 1.27
Distribution of genes encoding putative transmissibility factors among epidemic and nonepidemic strains of Burkholderia cepacia from cystic fibrosis patients in the United Kingdom. J Clin Microbiol (2000) 1.24
The epidemiological type identification of Serratia marcescens from outbreaks of infection in hospitals. J Hyg (Lond) (1980) 1.24
Polyagglutinating and non-typable strains of Pseudomonas aeruginosa in cystic fibrosis. J Med Microbiol (1986) 1.23
Home-use nebulizers: a potential primary source of Burkholderia cepacia and other colistin-resistant, gram-negative bacteria in patients with cystic fibrosis. J Clin Microbiol (1996) 1.22
Preparation of agglutinating antisera specific for the flagellar antigens of Pseudomonas aeruginosa. J Med Microbiol (1981) 1.22
Auxotrophy of Pseudomonas aeruginosa in cystic fibrosis. FEMS Microbiol Lett (1992) 1.21
Fatal pulmonary infection with Mycobacterium fortuitum in cystic fibrosis. Br J Dis Chest (1984) 1.18
No added benefit from nebulized amiloride in patients with cystic fibrosis. Eur Respir J (1993) 1.18
Beclomethasone dipropionate aerosol in asthma. Transfer of steroid-dependent asthmatic patients from oral prednisone to beclomethasone dipropionate aerosol. Am Rev Respir Dis (1974) 1.17
New bacteriophage typing scheme for subdivision of the frequent capsular serotypes of Klebsiella spp. J Clin Microbiol (1987) 1.17
Enteric coated microspheres of pancreatin in the treatment of cystic fibrosis: comparison with a standard enteric coated preparation. Thorax (1987) 1.15
Vasculitis complicating cystic fibrosis. Q J Med (1989) 1.14
Cross infection of cystic fibrosis patients with Pseudomonas aeruginosa. Thorax (2002) 1.14
Auxotrophy of Burkholderia (Pseudomonas) cepacia from cystic fibrosis patients. J Clin Microbiol (1995) 1.14
Nasal epithelial ion transport and genetic analysis of infertile men with congenital bilateral absence of the vas deferens. Hum Mol Genet (1993) 1.14
Isolation of Acinetobacter spp. including A. baumannii from vegetables: implications for hospital-acquired infections. J Hosp Infect (1999) 1.14
Two years experience with recombinant human DNase I in the treatment of pulmonary disease in cystic fibrosis. Respir Med (1995) 1.13
PSE-4 beta lactamase: a serotype-specific enzyme in Pseudomonas aeruginosa. J Med Microbiol (1985) 1.12
Biology of Pseudomonas aeruginosa in relation to pulmonary infection in cystic fibrosis. J R Soc Med (1986) 1.12
O serotyping scheme for Enterobacter cloacae. J Clin Microbiol (1983) 1.12
An outbreak of melioidosis in imported primates in Britain. Vet Rec (1992) 1.11
State of the art: typing Pseudomonas aeruginosa. J Hosp Infect (1980) 1.11
Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF. European Epidemiologic Registry of Cystic Fibrosis. Eur Respir J (2001) 1.11
The arthropathy of cystic fibrosis. Ann Rheum Dis (1988) 1.10
In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis. Thorax (1996) 1.09
Pseudomonas cepacia: pulmonary infection in patients with cystic fibrosis. Respir Med (1993) 1.09